← Back to Search

Connected Care for Community Health

N/A
Waitlist Available
Led By Stacy Lindau, MD, MAPP
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up annual, up to 6 years
Awards & highlights

Study Summary

This trial will evaluate whether providing patients with information about community resources and a community health worker can lead to better health outcomes and lower total cost of care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~annual, up to 6 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and annual, up to 6 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cost per beneficiary per year
Secondary outcome measures
Change in HbA1c control
Change in HealtheRx Understandability (participant survey, the percent of program participants who report that their HealtheRx is easy to understand)
Change in HealtheRx delivery (providers communicate to patients about the HealtheRx)
+12 more
Other outcome measures
Change in % of eligible patients receiving a HealtheRx
Change in number of CommunityRx reports delivered (Number of CommunityRx reports created and given to community organizations)
Change in number of places mapped (community organizations, identified in the geographic region)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
This group of patients receives the HealtheRx.
Group II: Control groupActive Control1 Intervention
This group of patients does not receive the HealtheRx
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HealtheRx
2015
N/A
~420

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,002 Previous Clinical Trials
617,850 Total Patients Enrolled
Stacy Lindau, MD, MAPPPrincipal InvestigatorUniversity of Chicago
1 Previous Clinical Trials
2,000 Total Patients Enrolled

Media Library

HealtheRx Clinical Trial Eligibility Overview. Trial Name: NCT02411409 — N/A
Connected Care Research Study Groups: Intervention group, Control group
Connected Care Clinical Trial 2023: HealtheRx Highlights & Side Effects. Trial Name: NCT02411409 — N/A
HealtheRx 2023 Treatment Timeline for Medical Study. Trial Name: NCT02411409 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Impact of the CommunityRx Program on Health, Service Utilization and Costs
2013. "Impact of the CommunityRx Program on Health, Service Utilization and Costs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02411409.
~16552 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top